Ascendis Pharma A/S (ASND Quick QuoteASND - Free Report) was a big mover last session, as its shares rose over 7% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend for the company as the stock is now up over 21% in the past one-month time frame.

None of the estimates for this stock were revised over the past 30 days. The Zacks Consensus Estimate also remained unchanged over the same time frame. Yesterday’s price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Ascendis currently carries a Zacks Rank #2 (Buy), while its Earnings ESP is 0.00%.

Ascendis Pharma A/S Price

 

Ascendis Pharma A/S Price | Ascendis Pharma A/S Quote

Another favorably placed stock in the Medical – Biomedical and Genetics space is Cellectis S.A. (CLLS Quick QuoteCLLS - Free Report) , sporting a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Zacks' Top Investment Ideas for Long-Term Profit

How would you like to see our best recommendations to help you find today’s most promising long-term stocks? Starting now, you can look inside our portfolios featuring stocks under $10, income stocks, value investments and more. These picks, which have double and triple-digit profit potential, are rarely available to the public. But you can see them now. Click here >>